DOCSLIB.ORG

PSI Scientific Report 2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PSI Scientific Report 2010 PSI Scientific Report 2010 Paul Scherrer Institut, 5232 Villigen PSI, Switzerland Tel. +41 (0)56 310 21 11, Fax +41 (0)56 310 21 99 www.psi.ch PSI Scientific Report 2010 Cover photo: PSI researchers Marcel Hofer and Jérôme Bernard working an Pharmacist Susanne Geistlich preparing a fuel-cell system developed in the inactive components of a collaboration with Belenos Clean radio pharmaceutic at PSI‘s Center for Power AG. Radiopharmaceutical Sciences. (Photo: Scanderbeg Sauer Photography) (Photo: Scanderbeg Sauer Photography) PSI Scientifi c Report 2010 PSI Scientifi c Report 2010 Published by Paul Scherrer Institute Editor Paul Piwnicki English language editing Trevor Dury Coordination Evelyne Gisler Design and Layout Irma Herzog Photographs PSI, unless stated otherwise Printing Sparn Druck + Verlag AG, Möhlin Available from Paul Scherrer Institute Communications Services 5232 Villigen PSI, Switzerland Phone +41 (0)56 310 21 11 www.psi.ch PSI public relations [email protected] Communications offi cer Dagmar Baroke ISSN 1662-1719 Copying is welcomed, provided the source is acknowledged and an archive copy sent to PSI. Paul Scherrer Institute, April 2011 Table of contents 3 4 World-class research benefi ts our industry Foreword from the director 7 SwissFEL 17 Research focus and highlights 18 Synchrotron light 28 Neutrons and muons 36 Particle physics 40 Micro- and nanotechnology 44 Biomolecular research 48 Radiopharmacy 52 Nuclear Chemistry 54 Large research facilities 56 Proton Therapy 60 General Energy 70 CCEM-CH 72 Nuclear energy and safety 84 Environment and energy systems analysis 91 User facilities 92 PSI accelerators 96 Swiss Light Source (SLS) 98 Spallation Neutron Source (SINQ) 100 Ultra-Cold Neutron Source (UCN) 102 Swiss Muon Source (SμS) 105 Technology transfer 111 Facts and fi gures 112 PSI in 2010 – an overview 114 Commission and committees 116 Organizational Structure 117 Publications Photo: Scanderbeg Sauer Photography Foreword 5 World-class research benefi ts our industry Dear Reader, DECTRIS. This company is now selling its products all over the What do automobile components, batteries, chain saws, choco- world and, for this achievement, received the Swiss Economic late, computer processors, concrete, fuel cells, luxury watches, Award in June 2010. Currently, scientists at PSI and DECTRIS are medicines, satellites, semiconductors, soap and yoghurt all have investigating the potential of this technology for applications in common? The answer is that they, among many other objects, in the fi eld of medical imaging. have all been examined at the Paul Scherrer Institute by indus- Beside these two examples, numerous other technologies de- trial companies. Looking inside a combustion engine or a bio- veloped at PSI are now used by industry; for example, power molecule is possible through the use of the large-scale scien- supplies for highly dynamic magnets, high-precision step-motor tifi c facilities of PSI: the Swiss Light Source (SLS), the Spallation control systems, various components for proton-therapy treat- Neutron Source (SINQ), and the Swiss Muon Source (SμS), or the ments, catalysts for exhaust gas aft er-treatment, fuel cells as hot-cells for radioactive materials. These facilities are all avail- power supplies, or optical components for neutron sources, as able for industrial partners to use, for investigations that are not produced by SwissNeutronics, another PSI spin-off company. possible anywhere else in Switzerland, or – in some cases – even The next large facility to be built at PSI will be the SwissFEL X-ray anywhere in the world. free-electron laser. In building this facility, it is one of our highest Besides this direct use of PSI facilities by industry, other indirect priorities to involve future users at the earliest possible stage of benefi ts also exist for industry from PSI’s own internal develop- its conception, as we want to provide a facility which is pre- ments. Indeed, PSI scientists oft en require technologies for their cisely tailored to the needs of Swiss research groups in both own experiments that are not available on the market and this universities and industry. At the same time, we are being con- therefore necessitates specifi c in-house development to achieve fronted by considerable technological challenges, which we want a solution. It regularly happens that PSI products which derive to solve together with industrial partners. In this way, know-how from such developments can be used in various other types of from PSI will – again – be transferred to industry, enabling the industrial applications. Two particularly notable examples of companies involved to acquire knowledge and innovation capa- such technology transfers originated from fundamental research bilities. at PSI. To conclude, although it is clear that most research performed The fi rst is an oscilloscope, the size of a thumbnail, which had at PSI is of a fundamental character, considerable direct and been developed for precision experiments at PSI and can per- indirect benefi ts also result for our industry and, consequently, form the same functions as a conventional device the size of a our society, not to mention the benefi ts which accrue from the shoebox. PSI is currently looking for the best way to market this signifi cant training and educational component of PSI’s mission. product. In the second example, PSI researchers developed an innovative detector for the CMS experiment at the new Large Hadron Collider (LHC) at CERN, to reveal the presence and paths of elementary particles. Further adaptation of this device for Professor Dr. Joël Mesot X-ray detection resulted in the creation of the spin-off company Director, Paul Scherrer Institute SwissFEL 7 8 SwissFEL – Project overview and An important milestone in the realization of the new SwissFEL facil- new developments ity was reached on 24 August 2010, when the core of the new Swiss Free-Electron Laser facility (SwissFEL) was set into operation at the Paul Scherrer Institute. The newly inaugurated injector pre-project is motivated by the challenging electron beam requirements necessary for the SwissFEL accelerator facility. Its main goal is to extensively study the generation, transport and time compression of high- brightness beams and to support the component development necessary for the SwissFEL Project. The new SwissFEL facility will open the door to discoveries, in many areas of current research, that cannot be achieved using existing methods. The unique properties of the SwissFEL will enable experi- ments to be carried out at a very high resolution in both time and space. For example, it will be possible to observe the progress of extremely fast chemical and physical processes, including details down to the scale of a molecule. This will not only result in a signifi cant increase in knowledge, it will also provide the basis for a vast range of technical and scientifi c developments. The SwissFEL Project is progressing very well and, in May 2010, the new SwissFEL web site went online: www.swissfel.ch. In July 2010, the SwissFEL Injector Conceptual Design Report – Accelerator Test Facility for SwissFEL (PSI Bericht Nr. 10-05) – was completed. Furthermore, the SwissFEL Conceptual Design Report (CDR – PSI Bericht Nr. 10-04) was published, describing the technical concepts and parameters used for the SwissFEL baseline design. Both documents are available via the SwissFEL Website: http://www. swissfel.ch. The next highlight took place at the 32nd International Free-Electron Laser Conference in Malmö, Sweden, where the prestigious 2010 FEL Prize was awarded to Sven Reiche, of the SwissFEL Beam Dynamics Inauguration of the SwissFEL injector: team. Sven was presented with this award for his “outstanding con- Joël Mesot, PSI director, and Didier Burkhalter, Federal Councillor, tributions to the advancement of the fi eld of Free-Electron Laser at the injector tunnel. science and technology”. 8 SwissFEL PSI Scientifi c Report 2010 Preparations for SwissFEL science Bruce Patterson, Rafael Abela, Bill Pedrini, Mirjam van Daalen, Matthias Kläui, Hans Sigg, Jacinto Sa, Christoph Hauri, Izabela Czekaj, Anastasija Ichsanow, Jeroen van Bokhoven, Christian David, Vitaly Guzenko, SwissFEL Project, PSI Novel experimental methods for use in condensed matter science at the SwissFEL X-ray laser are being developed. These include the ultrafast initiation of surface catalytic reactions using terahertz pulses and cross-correlation analysis of scattering data from randomly-oriented particles. The ability at the SwissFEL to rapidly initiate a catalytic process will allow the characterization of short-lived intermediate states and will aid in the development of more effi cient catalysts. With cross-correlation scattering, it will be possible to track in detail the time-depend- ent conformations of biomolecules, and hence to follow their biological function. Beginning in the year 2017, the SwissFEL X-ray laser will provide curs more readily as one proceeds from Pd to Rh to Ru, along users with coherent, ultra-bright X-ray pulses, with a duration row 5 of the periodic table, and as one goes from a (111) to a of approximately 20 femtoseconds. Two important fi elds of (100) crystal surface. It is also believed that the energy bar- application for this facility are the characterization of short- rier involved, ΔEdiss, is a function of direction along the surface. lived intermediate states during catalytic chemistry and the Our proposal is to adjust the sample temperature to just below structural determination of biomolecules in solution. These the point where the thermally-induced reaction occurs and to are currently the subjects of investigation by the SwissFEL use directed half-cycle THz pulses to interact with the CO dipole Photonics Group at PSI. moment, eff ectively lowering ΔEdiss and hence momentarily increasing the reaction probability. Terahertz initiation of catalytic chemistry It is foreseen that the SwissFEL facility will include an inde- pendent, synchronized source of terahertz (THz) pump puls- es, which will permit THz-pump / X-ray probe experiments in condensed matter, without the complications of hot electron production by a visible laser.
Load more

Recommended publications
  • Μ → Eγ and Matching at Mw
    Eur. Phys. J. C (2016) 76:370 DOI 10.1140/epjc/s10052-016-4207-5 Regular Article - Theoretical Physics μ → eγ and matching at mW Sacha Davidson1,2,3,a 1 IPNL, CNRS/IN2P3, 4 rue E. Fermi, 69622 Villeurbanne Cedex, France 2 Université Lyon 1, Villeurbanne, France 3 Université de Lyon, 69622 Lyon, France Received: 18 March 2016 / Accepted: 14 June 2016 / Published online: 4 July 2016 © The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Several experiments search for μ ↔ e flavour attempt to reconstruct the fundamental Lagrangian of New change, for instance in μ → e conversion, μ → eγ and Physics from the operator coefficients. This is probably not μ → eee¯ . This paper studies how to translate these experi- feasible, but could give interesting perspectives. A first step mental constraints from low energy to a New Physics scale in this “bottom-up” approach, explored in this paper, is to M mW . A basis of QCD × QED-invariant operators (as use Effective Field Theory (EFT) [31] to translate the exper- appropriate below mW ) is reviewed, then run to mW with imental bounds to the coefficients of effective operators at one-loop Renormalisation Group Equations (RGEs) of QCD the New Physics scale M > mW . and QED. At mW , these operators are matched onto SU(2)- The goal would be to start from experimental constraints invariant dimension-six operators, which can continue to run on μ–e flavour change, and obtain at M the best bound up with electroweak RGEs. As an example, the μ → eγ on each coefficient from each observable.
    [Show full text]
  • NATO and Earth Scientists: an Ongoing Collaboration to Assess Geohazards and Contribute to Societal Security in Central Asia and the Caucasus
    Article 193 by Alessandro Tibaldi1*, Andrey M. Korzhenkov2, Federico Pasquarè Mariotto3, Derek Rust4, and Nino Tsereteli5 NATO and earth scientists: an ongoing collaboration to assess geohazards and contribute to societal security in Central Asia and the Caucasus 1 Department of Earth and Environmental Sciences, University of Milano-Bicocca, P. della Scienza 4, 20126 Milan, Italy; *Corresponding author, E-mail: [email protected] 2 Laboratory of modelling of seismic processes, Institute of Communication and Information Technologies, Kyrgyz-Russian Slavic University, Kievskaya str. 44, Bishkek 720000, Kyrgyz Republic 3 Department of Theoretical and Applied Sciences, University of Insubria, Via Mazzini 5, 21100 Varese, Italy 4 School of Earth and Environmental Sciences, University of Portsmouth, Barnaby Building, Portsmouth PO1 2UP, UK 5 M. Nodia Institute of Geophysics, M. Javakhishvili Tbilisi State University, 1, Alexidze str. 0171 T, Georgia (Received: July 18, 2017; Revised accepted: February 26, 2018) https://doi.org/10.18814/epiiugs/2018/018011 Geological features and hazards have no geographical and political boundaries. The North Atlantic Treaty Introduction Organization (NATO) has been funding several interna- tional Earth Science research projects in Central Asia Several areas on Earth are subject to natural hazards that threaten and the Caucasus over the last ten years. The projects are human life, settlements and infrastructures. One of the natural haz- ards that may severely affect local areas and communities is an earth- aimed at improving the security of people and the safety quake, as seen, for instance, in the recent sequence of seismic events of infrastructures, and fostering peaceful scientific col- that struck the Caucasus: the 1988 earthquake in Spitak, Armenia laboration between scientists from NATO and non-NATO (Griffin et al., 1991), the 1991 and 2009 Racha (Georgia) earthquakes countries.
    [Show full text]
  • Repositioning of the Global Epicentre of Non-Optimal Cholesterol
    Article Repositioning of the global epicentre of non-optimal cholesterol https://doi.org/10.1038/s41586-020-2338-1 NCD Risk Factor Collaboration (NCD-RisC)* Received: 18 October 2019 Accepted: 2 April 2020 High blood cholesterol is typically considered a feature of wealthy western 1,2 Published online: 3 June 2020 countries . However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering Open access medications at varying rates. These changes can have distinct effects on the levels of Check for updates high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk— changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand.
    [Show full text]
  • Connecting Leading Candidates to the World's Finest Science Jobs, Events
    Connecting leading candidates to the world’s finest science jobs, events and other career development resources Click on the to navigate the pages PROMOTE YOUR RECRUITMENT ORGANIZATION EVENTS FILL YOUR VACANCIES BRANDED CONTENT & PROMOTE YOUR EVENTS Our Audience & Reach NATIVE ADVERTISING Multichannel marketing Job listing packages Custom Advertorials Nature Events Guide Employer Profile & Index Profile MULTICHANNEL MARKETING Custom Podcasts & Webcasts EXHIBIT AT CAREER EVENTS Banners *optimized targeting* Case Studies Careers Live Emails London • New York • Singapore Print EDITORIAL FEATURES Spotlights and Career Guides REGIONAL RECRUITMENT Salary Survey, Graduate Survey, Scientist At Work photo competition 2019 OTHER CALENDAR ABOUT US RESOURCES EDITORIAL CALENDAR NATURE CAREERS SPECS Print Specs NATURE RESEARCH Banner Specs Third Party Email Specs Alerts Specs SPRINGER NATURE TERMS & CONDITIONS CONTACT US UK/ROW: +44 (0)20 7843 4961 US: +1 212 726 9270 [email protected] 2 | Nature Careers 2019 Media Options RECRUITMENT PROMOTIONS EVENTS CALENDAR ABOUT US OTHER RESOURCES RECRUITMENT FILL YOUR VACANCIES Our Audience & Reach Job listing packages MULTICHANNEL MARKETING Banners *optimized targeting* Email Print REGIONAL RECRUITMENT 3 | Recruitment | Nature Careers 2019 Media Options RECRUITMENT PROMOTIONS EVENTS CALENDAR ABOUT US OTHER RESOURCES OUR AUDIENCE & REACH Nature Careers Nature Careers is the global career resource, jobs board and events directory for scientists. It is brought to you by Springer Nature, a leading publisher
    [Show full text]
  • Scalable Production of Biliverdin Ixα by Escherichia Coli Dong Chen1, Jason D Brown1, Yukie Kawasaki2, Jerry Bommer3 and Jon Y Takemoto1,2*
    Chen et al. BMC Biotechnology 2012, 12:89 http://www.biomedcentral.com/1472-6750/12/89 RESEARCH ARTICLE Open Access Scalable production of biliverdin IXα by Escherichia coli Dong Chen1, Jason D Brown1, Yukie Kawasaki2, Jerry Bommer3 and Jon Y Takemoto1,2* Abstract Background: Biliverdin IXα is produced when heme undergoes reductive ring cleavage at the α-methene bridge catalyzed by heme oxygenase. It is subsequently reduced by biliverdin reductase to bilirubin IXα which is a potent endogenous antioxidant. Biliverdin IXα, through interaction with biliverdin reductase, also initiates signaling pathways leading to anti-inflammatory responses and suppression of cellular pro-inflammatory events. The use of biliverdin IXα as a cytoprotective therapeutic has been suggested, but its clinical development and use is currently limited by insufficient quantity, uncertain purity, and derivation from mammalian materials. To address these limitations, methods to produce, recover and purify biliverdin IXα from bacterial cultures of Escherichia coli were investigated and developed. Results: Recombinant E. coli strains BL21(HO1) and BL21(mHO1) expressing cyanobacterial heme oxygenase gene ho1 and a sequence modified version (mho1) optimized for E. coli expression, respectively, were constructed and shown to produce biliverdin IXα in batch and fed-batch bioreactor cultures. Strain BL21(mHO1) produced roughly twice the amount of biliverdin IXα than did strain BL21(HO1). Lactose either alone or in combination with glycerol supported consistent biliverdin IXα production by strain BL21(mHO1) (up to an average of 23. 5mg L-1 culture) in fed-batch mode and production by strain BL21 (HO1) in batch-mode was scalable to 100L bioreactor culture volumes.
    [Show full text]
  • Personnel Law 2018
    2018 BOARD OF THE SWISS FEDERAL INSTITUTES OF TECHNOLOGY ETH BOARD PAUL SCHERRER INSTITUT PERSONNEL LAW BOARD OF THE SWISS FEDERAL INSTITUTES OF TECHNOLOGY ETH BOARD PAUL SCHERRER INSTITUT PERSONNEL LAW Imprint Personnel Law can be obtained at ETH Domain ETH Board Published by Human Resources ETH Board CH-8092 Zurich CH-8092 Zurich www.ethrat.ch Conception / Editor ETH Swiss Federal Institute Martin Sommer / Elisabeth Boettcher of Technology Zurich ETH Board Human Resources CH-8092 Zurich www.ethz.ch Layout and Print Paul Scherrer Institute EPFL Ecublens Human Resources ETH Board, January 2018 CH-1015 Lausanne 16th edition: March 2018 www.epfl.ch Paul Scherrer Institute Human Resources Management CH-5232 Villligen PSI www.psi.ch WSL Swiss Federal Institute for Forest, Snow and Landscape Research Human Resources CH-8903 Birmensdorf www.wsl.ch Empa Swiss Federal Institute of Materials Science & Technology Human Resources CH-8600 Duebendorf www.empa.ch Eawag Swiss Federal Institute of Aquatic Science and Technology Human Resources CH-8600 Duebendorf www.eawag.ch Contents Ordinance of the ETH Board concerning personnel in the Swiss Federal Institutes of Technology Domain (Personnel Ordinance for the ETH Domain, ETH PO) General Provisions 2 Human resources policy 4 Employment relationship 9 Benefits 15 Duties 38 Breach of professional duties 41 Final provisions 43 Appendices 47 Swiss Federal Personnel Law (FPL) General Provisions 54 Commencement and termination of employment 58 Rights and obligations resulting from the employment relationship 60 Data processing 64 Measures of benefit to personnel 70 Occupational Pension Scheme 72 Participation and social partnership 77 Formes of Procedure 78 Implementing Provisions 80 Final Provisions 81 Framework Ordinance for the Swiss Federal Personnel Law (Framework Ordinance FPL) 84 Table of contents Personnel Ordinance for the ETH Domain Chapter 1: General Provisions 2 Art.
    [Show full text]
  • On the Exotic Higgs Decays in Effective Field Theory
    Eur. Phys. J. C (2016) 76:514 DOI 10.1140/epjc/s10052-016-4362-8 Regular Article - Theoretical Physics On the exotic Higgs decays in effective field theory Hermès Bélusca-Maïtoa, Adam Falkowskib Laboratoire de Physique Théorique, Université Paris-Sud, Bat. 210, 91405 Orsay, France Received: 22 April 2016 / Accepted: 9 September 2016 / Published online: 22 September 2016 © The Author(s) 2016. This article is published with open access at Springerlink.com Abstract We discuss exotic Higgs decays in an effec- in powers of 1/. The leading effects are expected from tive field theory where the Standard Model is extended by operators of dimension 6, as their coefficients are suppressed dimension-6 operators. We review and update the status of by 1/2. The first classification of dimension-6 operators two-body lepton- and quark-flavor-violating decays involv- was performed in Ref. [1]. For one generation of fermions, ing the Higgs boson. We also comment on the possibility of a complete non-redundant set (henceforth referred to as a observing three-body flavor-violating Higgs decays in this basis) was identified and explicitly written down in Ref. [2]. context. Reference [3] extended this to three generations of fermions, in which case a basis is characterized by 2499 independent parameters. Contents In this paper we are interested in the subset of these operators that lead to exotic decays of the 125 GeV Higgs 1 Introduction ..................... 1 boson. By “exotic” we mean decays that are forbidden in 2 Exotic Higgs couplings from dimension-6 Lagrangian 2 the SM or predicted to occur with an extremely suppressed 3 Two-body Higgs decays ..............
    [Show full text]
  • The Swiss and Dutch Precision Industries
    The Swiss and Dutch Precision Industries Opportunities for R&D- cooperation between Switzerland and the Netherlands Innovation Attaché Network The Swiss and Dutch Precision Industries Opportunities for R&D-cooperation between Switzerland and the Netherlands Colofon Ordered by Netherlands Innovation Attaché Network Author Freek Deunk Innovation intern Supervision Erik van den Akker Head Economic Department Eelco van der Eijk Innovation counselor Saskia Harthoorn Senior economic officer Anita van Rozen Senior economic officer Contact [email protected] / [email protected] Date Augustus 2014 Published at: www.innovatie.ch/publicaties Source of the cover picture: http://www.hcatopsectoren.nl/htsm.html -1- Summary Switzerland and the Netherlands are strong and innovative countries with a long history in precision engineering. To increase the cooperation between the countries, this report has reviewed the respective precision engineering industries in both countries. This report could therefore serve as an introduction and reference manual on the relevant R&D-landscape in both countries for those parties who want to cooperate. The report focusses on ‘Mechatronics and Manufacturing’, ‘Components and Circuits’ and ‘Nanotechnology’, and the application-areas ‘Health-tech’, ‘Advanced Instrumentation’ and ‘Semiconductor equipment’. Both countries have top universities and competitive high-tech industries in these fields. The R&D environments in both countries could well work together, as the “precision” of Switzerland may supplement the “creativity” of the Netherlands. Both countries are open and internationally oriented, which is a good start for cooperation, building and extending already existing connections. The role of the governments should be a facilitating one. On both sides research institutes and companies appreciate the network and introductions government bodies can give.
    [Show full text]
  • Downloads Presented on the Abstract Page
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.27.063578; this version posted April 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A systematic examination of preprint platforms for use in the medical and biomedical sciences setting Jamie J Kirkham1*, Naomi Penfold2, Fiona Murphy3, Isabelle Boutron4, John PA Ioannidis5, Jessica K Polka2, David Moher6,7 1Centre for Biostatistics, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom. 2ASAPbio, San Francisco, CA, USA. 3Murphy Mitchell Consulting Ltd. 4Université de Paris, Centre of Research in Epidemiology and Statistics (CRESS), Inserm, Paris, F-75004 France. 5Meta-Research Innovation Center at Stanford (METRICS) and Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics, Stanford University, Stanford, CA, USA. 6Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. 7School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada. *Corresponding Author: Professor Jamie Kirkham Centre for Biostatistics Faculty of Biology, Medicine and Health The University of Manchester Jean McFarlane Building Oxford Road Manchester, M13 9PL, UK Email: [email protected] Tel: +44 (0)161 275 1135 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.27.063578; this version posted April 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • BSG 50Th Annual Conference, 7
    BSG 2021 50th Annual Conference 7 - 9 July 2021 Hosted online by Lancaster University Ageing Past, Present and Future: Innovation and Change Conference Programme Image courtesy of Tom Morbey British50th Annual Society Conference of Gerontology / 7 - 9 July 2021 AnnualHosted online Conference by Lancaster 2017 University SEARCH DOCUMENT To search this document you can click the button above or bring up the Search window by pressing Ctrl-F (Windows) or Command+F (Mac). © Copyright Author 2 2britishgerontology.orgbritishgerontology.org Contents Welcome from the BSG President ........................... 4 Flagship Symposium ................................................. 19 Welcome from the Vice Chancellor, The Averil Osborn Symposium .............................. 20 Lancaster University ..................................................... 5 Sponsors and Exhibitors .......................................... 21 Welcome from the Conference Chair ..................... 5 BSG Emergening Researchers in Ageing ........... 22 Thanks ............................................................................... 7 Conference Ceremonies ........................................... 23 Conference Committee ................................................ 8 Social Events ................................................................ 23 About the Conference ............................................... 10 Join the BSG ................................................................. 27 Timetable at a Glance ..............................................
    [Show full text]
  • Springer Nature’S Hybrid Results of the DEAL- Journals, of Which 9,354 Were of the Research Article Type and 882 of the Non-Research Article Type
    Advancing Open Access Publishing in 2020 10,236 publications were published in 2020 through the DEAL agreement in Springer Nature’s hybrid Results of the DEAL- journals, of which 9,354 were of the research article type and 882 of the non-research article type. Another 1,843 articles appeared in Springer Nature’s fully open access journals. Springer Nature Agreement 12079 ARTICLES Authors from 390 different German scientific institutions were involved in these publications. 2020 Authors retaining their rights Open access publishing across disciplines Springer Nature is the second By the end of 2020, 96% of authors According to the disciplines of Scopus, DEAL publications most relevant publisher for chose open access for publishing in in Springer Nature journals were distributed as follows in Elsevier German authors. Springer Nature’s hybrid journals. Their 2020: articles were published under a free Others Health sciences Springer license (CC-BY) without any access Nature In 2020, 18% of all scientific barriers and may thus be disseminated Life sciences articles from Germany were and re-used worldwide. The number Physical sciences Wiley published in Springer Nature of publications for which authors Social sciences + Humanities journals. opted out of open access continues to Other/Multidisciplinary decline. 0 500 1000 1500 2000 2500 3000 3500 4000 Publish and read Open access to key research While authors at over 900 institutions in Springer Nature journals are among the most frequently used publication venues of authors in Germany. Numerous of their Germany are automatically entitled to publish medical and, especially, clinical medicine titles are particularly relevant for German research.
    [Show full text]
  • Coexistence of Phycoerythrin and a Chlorophyll A/B Antenna in a Marine Prokaryote (Prochlorophyta/Cyanobacteria/Phycobilins/Photosynthesis/Endosymbiosis) WOLFGANG R
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 11126-11130, October 1996 Microbiology Coexistence of phycoerythrin and a chlorophyll a/b antenna in a marine prokaryote (Prochlorophyta/cyanobacteria/phycobilins/photosynthesis/endosymbiosis) WOLFGANG R. HESs*t, FREDEIRIC PARTENSKYt, GEORG W. M. VAN DER STAAYI, JOSE' M. GARCIA-FERNANDEZt, THOMAS BORNER*, AND DANIEL VAULOTt *Department of Biology, Humboldt-University, Chausseestrasse 117, D-10115 Berlin, Germany; and tStation Biologique de Roscoff, Centre National de la Recherche Scientifique Unite Propre de Recherche 9042 and Universite Pierre et Marie Curie, BP 74, F-29682 Roscoff Cedex, France Communicated by Hewson Swift, The University of Chicago, Chicago, IL, July 1Z 1996 (received for review June 7, 1996) ABSTRACT Prochlorococcus marinus CCMP 1375, a ubiq- tation maximum of the major chromophore bound by PE-III uitous and ecologically important marine prochlorophyte, corresponds to that of phycourobilin. was found to possess functional genes coding for the a and 1 subunits of a phycobiliprotein. The latter is similar to phy- coerythrins (PE) from marine Synechococcus cyanobacteria MATERIALS AND METHODS and bind a phycourobilin-like pigment as the major chro- Flow Cytometric Measurements. Sea water samples were mophore. However, differences in the sequences of the ca and collected at different depths during the France-Joint Global 13 chains compared with known PE subunits and the presence Ocean Flux Study OLIPAC cruise held in November 1994 of a single bilin attachment site on the a subunit designate it aboard the N.O. l'Atalante. Samples were analyzed immedi- as a novel PE type, which we propose naming PE-III. P. ately using a FACScan (Becton Dickinson) flow cytometer and marinus is the sole prokaryotic organism known so far that cell concentrations of Prochlorococcus and Synechococcus contains chlorophylls a and b as well as phycobilins.
    [Show full text]